It can be concluded that the miR-340, LGR5, and FOXO1 genes can be targeted for safer treatment and preservation of reproductive ability in patients with ovarian cancer by prevention of oophorectomy and/or high prescription of chemotherapy drugs. The gene discussed is FOXO1; the disease is ovarian carcinoma.